Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 41801-41850 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05243069
Head and Neck Cancer Patient Symptom and Oncologic Outcomes
NARecruiting
80 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05346809
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
PHASE2Recruiting
39 participants
Started: Mar 31, 2023 · Completed: Sep 30, 2026
4 conditions2 sponsors2 locations
NCT05794529
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
N/ARecruiting
30 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05769010
Study of SHR-A1811 in HER2-expression Advanced Breast Cancer with Brain Metastases
PHASE2Recruiting
125 participants
Started: Mar 31, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05317728
Clinical Study of a Fluid Accommodating Intraocular Lens (IOL) Design
NARecruiting
175 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor6 locations
NCT05608681
A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).
PHASE1/PHASE2Recruiting
117 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor7 locations
NCT05770349
Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure
N/ARecruiting
45 participants
Started: Mar 31, 2023 · Completed: Feb 28, 2027
2 conditions2 sponsors1 location
NCT05804136
Duramesh™ vs Polydioxanone Suture for Laparotomy Closure
NARecruiting
230 participants
Started: Mar 31, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05736978
Adaptive Treatment for Acute Myeloid Leukemia Based on D14 MRD Results
PHASE2Recruiting
58 participants
Started: Mar 31, 2023 · Completed: Mar 15, 2027
2 conditions1 sponsor4 locations
NCT05595603
Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage
PHASE2Recruiting
153 participants
Started: Mar 31, 2023 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT05734313
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
NARecruiting
94 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2027
2 conditions3 sponsors2 locations
NCT05452733
Toward a Real-time Access to Sleepers' Mental Content
NARecruiting
200 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2027
3 conditions2 sponsors1 location
NCT05540288
NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions
PHASE3Recruiting
266 participants
Started: Mar 31, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor13 locations
NCT06031181
Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)
PHASE3Recruiting
390 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2030
3 conditions1 sponsor1 location
NCT05794178
Testing Responses of Young Adults to Intervention Messages for Promoting Physical Activity Trial
NARecruiting
360 participants
Started: Mar 31, 2023 · Completed: Nov 30, 2026
2 conditions2 sponsors2 locations
NCT05793554
CLASSICA: Validating AI in Classifying Cancer in Real-Time Surgery
N/ARecruiting
600 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2027
3 conditions12 sponsors1 location
NCT05723250
Care Coordination Educational Intervention Study for Patients from Rural Areas with Early Stage Cancer
NARecruiting
40 participants
Started: Mar 31, 2023 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT05779813
Genetic Frontotemporal Dementia Initiative for Neurodevelopment
N/ARecruiting
200 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2035
2 conditions1 sponsor1 location
NCT06864000
Phenotypic and Molecular Characterisation of Cerebral Amyloid Angiopathy
N/ARecruiting
100 participants
Started: Mar 31, 2023 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT05748366
Ultrasound Guided Serratus Anterior Plane Block for Rib Fractures
NARecruiting
60 participants
Started: Mar 31, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05753566
Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
PHASE2Recruiting
96 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2028
2 conditions2 sponsors2 locations
NCT05528900
A Multicentre French Prospective Study of Children With Food Protein Induced Enterocolitis Syndrome in Its Acute Form
NARecruiting
600 participants
Started: Mar 31, 2023 · Completed: Oct 31, 2028
1 condition1 sponsor19 locations
NCT05562167
The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
PHASE2Recruiting
75 participants
Started: Mar 31, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06875245
Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals
PHASE4Recruiting
100 participants
Started: Mar 31, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05796973
Measuring Oncological Value of Exercise and Statin
PHASE3Recruiting
240 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2027
12 conditions5 sponsors1 location
NCT05774951
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
PHASE3Recruiting
4,300 participants
Started: Mar 31, 2023 · Completed: May 29, 2036
1 condition1 sponsor722 locations
NCT05328258
Use of GnRHa During Chemotherapy for Fertility Protection
PHASE3Recruiting
500 participants
Started: Mar 31, 2023 · Completed: Jan 31, 2032
6 conditions1 sponsor17 locations
NCT04685200
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
N/ARecruiting
143 participants
Started: Mar 31, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05723107
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
PHASE1Recruiting
15 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT05508256
CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction
PHASE4Recruiting
1,548 participants
Started: Mar 31, 2023 · Completed: Jul 31, 2027
3 conditions4 sponsors1 location
NCT05772390
Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation
PHASE2Recruiting
68 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2032
2 conditions1 sponsor1 location
NCT05317403
Venetoclax to Augment Epigenetic Modification and Chemotherapy
PHASE1Recruiting
40 participants
Started: Mar 31, 2023 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT05887011
CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia
N/ARecruiting
2,000 participants
Started: Mar 31, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor41 locations
NCT05774743
Pediatric Anesthesia Consent - Visual Aids
NARecruiting
140 participants
Started: Mar 31, 2023 · Completed: May 1, 2025
2 conditions1 sponsor1 location
NCT06391788
Efficacy and Safety of Thoracoscopic Morrow Surgery in the Treatment of Hypertrophic Obstructive Cardiomyopathy
NARecruiting
132 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2025
2 conditions1 sponsor1 location
NCT05869968
SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI
N/ARecruiting
140 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2027
5 conditions3 sponsors1 location
NCT05796531
Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization
NARecruiting
155 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2026
3 conditions3 sponsors1 location
NCT05602376
Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging
NARecruiting
3,642 participants
Started: Mar 31, 2023 · Completed: May 31, 2027
3 conditions4 sponsors2 locations
NCT05742425
Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases
PHASE2Recruiting
30 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2028
2 conditions2 sponsors1 location
NCT06266039
Introduction of Long Acting Buprenorphine in France
N/ARecruiting
223 participants
Started: Mar 31, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05468567
Three-dimensional Perception of Sounds in Military with Acoustic Trauma
N/ARecruiting
46 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05590871
FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension
NARecruiting
180 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor27 locations
NCT05883696
Palliative Care Needs Among Elderly People at Emergency Department
N/ARecruiting
300 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05754008
Care Navigator Support for Younger Latinx Adults With Type 2 Diabetes
NARecruiting
204 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06350656
Study of Cerebral Compliance in Neurosurgical Intensive Care Units (EC2)
N/ARecruiting
30 participants
Started: Mar 31, 2023 · Completed: Apr 30, 2024
1 condition1 sponsor7 locations
NCT05683587
Effect of Ballet Course on Lower Limb Strength, Balance, Working Memory and the Compliance and Satisfaction
NARecruiting
30 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT05741333
In-Office Clinical Study of the Solo+ TTD
NARecruiting
66 participants
Started: Mar 30, 2023 · Completed: Jun 30, 2027
2 conditions1 sponsor7 locations
NCT05727904
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
PHASE3Recruiting
670 participants
Started: Mar 30, 2023 · Completed: Mar 1, 2030
3 conditions1 sponsor72 locations
NCT05749588
FUSCC Refractory TNBC Platform Study (FUTURE2.0)
PHASE2Recruiting
120 participants
Started: Mar 30, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05568680
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
PHASE1Recruiting
42 participants
Started: Mar 30, 2023 · Completed: Dec 31, 2027
3 conditions1 sponsor4 locations